Abstract not availableJoanne N. Luke, Alex Brown, Mark Daniel, Kerin O’Dea, James D. Best, Alicia J. Jenkins, Zhiqiang Wang, Robyn A. McDermott, Zaimin Wang, Kevin G. Rowle
OBJECTIVE: To assess the prevalence of metabolic syndrome, and its effect on cardiovascular morbidit...
Cardiovascular disease is the leading cause of death in New Zealand. There is the potential to preve...
Introduction: For Aboriginal populations, predicting individuals at risk of cardiovascular disease (...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
[Extract] We thank Dr. Tomoyuki Kawada for their letter and for the important issues raised. We reit...
[Extract] We thank Dr. Tomoyuki Kawada for their letter and for the important issues raised. We reit...
Objective : To compare the prevalence of the Metabolic Syndrome (MetS) defined by four definitions a...
In the clinical setting, calculating cardiovascular disease (CVD) risk is commonplace but the utilit...
This report aims to compare the prediction of the metabolic syndrome (MetS) and its components for m...
This report aims to compare the prediction of the metabolic syndrome (MetS) and its components for m...
In the clinical setting, calculating cardiovascular disease (CVD) risk is commonplace but the utilit...
This report aims to compare the prediction of the metabolic syndrome (MetS) and its components for m...
OBJECTIVE: To assess the prevalence of metabolic syndrome, and its effect on cardiovascular morbidit...
Cardiovascular disease is the leading cause of death in New Zealand. There is the potential to preve...
Introduction: For Aboriginal populations, predicting individuals at risk of cardiovascular disease (...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
We investigated if the metabolic syndrome (MetS) and its component risk factors predict cardiovascul...
[Extract] We thank Dr. Tomoyuki Kawada for their letter and for the important issues raised. We reit...
[Extract] We thank Dr. Tomoyuki Kawada for their letter and for the important issues raised. We reit...
Objective : To compare the prevalence of the Metabolic Syndrome (MetS) defined by four definitions a...
In the clinical setting, calculating cardiovascular disease (CVD) risk is commonplace but the utilit...
This report aims to compare the prediction of the metabolic syndrome (MetS) and its components for m...
This report aims to compare the prediction of the metabolic syndrome (MetS) and its components for m...
In the clinical setting, calculating cardiovascular disease (CVD) risk is commonplace but the utilit...
This report aims to compare the prediction of the metabolic syndrome (MetS) and its components for m...
OBJECTIVE: To assess the prevalence of metabolic syndrome, and its effect on cardiovascular morbidit...
Cardiovascular disease is the leading cause of death in New Zealand. There is the potential to preve...
Introduction: For Aboriginal populations, predicting individuals at risk of cardiovascular disease (...
DOI
Add to ORKG